These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19832828)

  • 41. Prescribing in pregnancy and during breast feeding: using principles in clinical practice.
    Henderson E; Mackillop L
    Postgrad Med J; 2011 May; 87(1027):349-54. PubMed ID: 21273359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Medication use in early pregnancy-prevalence and determinants of use in a prospective cohort of women.
    Cleary BJ; Butt H; Strawbridge JD; Gallagher PJ; Fahey T; Murphy DJ
    Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):408-17. PubMed ID: 20099251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prescription drug use in pregnancy and variations according to prior psychiatric history.
    Ingstrup KG; Liu X; Gasse C; Debost JP; Munk-Olsen T
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):105-113. PubMed ID: 29171114
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A population analysis of prescriptions for asthma medications during pregnancy.
    Zetstra-van der Woude PA; Vroegop JS; Bos HJ; de Jong-van den Berg LT
    J Allergy Clin Immunol; 2013 Mar; 131(3):711-7. PubMed ID: 23063582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Periconceptional folic acid and teratogenic drug use in women undergoing fertility treatments.
    Riskin-Mashiah S; Auslender R
    J Matern Fetal Neonatal Med; 2012 Oct; 25(10):1899-903. PubMed ID: 22372485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nationwide register-based surveillance system on drugs and pregnancy in Finland 1996-2006.
    Artama M; Gissler M; Malm H; Ritvanen A;
    Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):729-38. PubMed ID: 21626607
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations.
    Huybrechts KF; Hernández-Díaz S; Patorno E; Desai RJ; Mogun H; Dejene SZ; Cohen JM; Panchaud A; Cohen L; Bateman BT
    JAMA Psychiatry; 2016 Sep; 73(9):938-46. PubMed ID: 27540849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Final results from 18 years of the International Lamotrigine Pregnancy Registry.
    Cunnington MC; Weil JG; Messenheimer JA; Ferber S; Yerby M; Tennis P
    Neurology; 2011 May; 76(21):1817-23. PubMed ID: 21606453
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and predictors of anti-infective use during pregnancy.
    Santos F; Oraichi D; Bérard A
    Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):418-27. PubMed ID: 20119971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes.
    Bérard A; Zhao JP; Shui I; Colilla S
    Ann Rheum Dis; 2018 Apr; 77(4):500-509. PubMed ID: 29222350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increasing use of antibiotics in pregnancy during the period 2000-2010: prevalence, timing, category, and demographics.
    Broe A; Pottegård A; Lamont RF; Jørgensen JS; Damkier P
    BJOG; 2014 Jul; 121(8):988-96. PubMed ID: 24754708
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Congenital abnormalities in children of 43 pregnant women who attempted suicide with large doses of nitrazepam.
    Gidai J; Acs N; Bánhidy F; Czeizel AE
    Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):175-82. PubMed ID: 19998314
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Associations Between ADHD Medication Use in Pregnancy and Severe Malformations Based on Prenatal and Postnatal Diagnoses: A Danish Registry-Based Study.
    Kolding L; Ehrenstein V; Pedersen L; Sandager P; Petersen OB; Uldbjerg N; Pedersen LH
    J Clin Psychiatry; 2021 Jan; 82(1):. PubMed ID: 33406323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prescribing in pregnant women with inflammatory bowel disease and its relationship to congenital malformations in Japan.
    Takahashi S; Kakuta Y; Obara T; Ishikawa T; Nagai H; Shimoyama Y; Naito T; Moroi R; Shiga H; Mano N; Kinouchi Y; Masamune A
    J Gastroenterol Hepatol; 2024 Jul; 39(7):1291-1298. PubMed ID: 38538533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fetal Exposure to Montelukast and Congenital Anomalies: A Population Based Study in Denmark.
    Cavero-Carbonell C; Vinkel-Hansen A; Rabanque-Hernández MJ; Martos C; Garne E
    Birth Defects Res; 2017 Apr; 109(6):452-459. PubMed ID: 28398707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. One disease, two lives.
    Visco AG; Meyer LC; Xi S; Brown CG
    Clin J Oncol Nurs; 2009 Aug; 13(4):426-32. PubMed ID: 19648099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillance.
    MacDonald SC; Cohen JM; Panchaud A; McElrath TF; Huybrechts KF; Hernández-Díaz S
    Pharmacoepidemiol Drug Saf; 2019 Sep; 28(9):1211-1221. PubMed ID: 31328328
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Quebec Pregnancy Cohort: prevalence of medication use during gestation and pregnancy outcomes].
    Bérard A; Sheehy O
    Therapie; 2014; 69(1):71-81. PubMed ID: 24698191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drugs associated with teratogenic mechanisms. Part I: dispensing rates among pregnant women in the Netherlands, 1998-2009.
    van Gelder MM; Bos JH; Roeleveld N; de Jong-van den Berg LT
    Hum Reprod; 2014 Jan; 29(1):161-7. PubMed ID: 24105826
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A 2-year evaluation of questions concerning "Drugs--Pregnancy" at the CRPV in Nantes March 1992--March 1994].
    Chiffoleau A; Veyrac G; Baudot S; Larousse C
    Therapie; 1995; 50(5):429-38. PubMed ID: 8571281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.